BMY Jan 2025 100.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 12:24PM EDT. Market open.
| Previous close | 0.0500 |
| Open | 0.0300 |
| Bid | 0.0100 |
| Ask | 0.2000 |
| Strike | 100.00 |
| Expiry date | 2025-01-17 |
| Day's range | 0.0300 - 0.0500 |
| Contract range | N/A |
| Volume | |
| Open interest | 367 |
Business WireU.S. Food and Drug Administration Accepts Bristol Myers Squibb’s Application for Subcutaneous Nivolumab (nivolumab and hyaluronidase)
PRINCETON, N.J., May 06, 2024--U.S. Food and Drug Administration Accepts Bristol Myers Squibb’s Application for Subcutaneous Nivolumab (nivolumab and hyaluronidase)
Business WireEuropean Medicines Agency Validates Bristol Myers Squibb’s Application for Opdivo (nivolumab) Plus Yervoy (ipilimumab) for the First-Line Treatment of Adult Patients with Microsatellite...
PRINCETON, N.J., May 06, 2024--European Medicines Agency Validates Bristol Myers Squibb’s Application for Opdivo (nivolumab) Plus Yervoy (ipilimumab) for the First-Line....
Simply Wall St.Bristol-Myers Squibb (NYSE:BMY) shareholders have endured a 33% loss from investing in the stock a year ago
It's easy to match the overall market return by buying an index fund. When you buy individual stocks, you can make...
© 2024 Yahoo. All rights reserved.